Venaxis signs agreement with European distributor, gets first APPY1 order
CASTLE ROCK – Venaxis Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA approval for its blood-based appendicitis test, announced it has signed its first European commercial...
View ArticleVenaxis expands European distribution network for APPY1 appendicitis test
CASTLE ROCK – Venaxis Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on gaining FDA approval and commercialization of its APPY1 appendicitis test, announced it has signed agreements with...
View Article
More Pages to Explore .....